Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy

被引:3
|
作者
Kuroda, Junya [1 ]
Mizutani, Shinsuke [1 ]
Shimura, Yuji [1 ]
Maegawa, Saori [1 ]
Nagoshi, Hisao [1 ]
Chinen, Yoshiaki [1 ]
Tatekawa, Shotaro [1 ]
Tsukamoto, Taku [1 ]
Mizuno, Yoshimi [1 ]
Yamamoto-Sugitani, Mio [1 ]
Kobayashi, Tsutomu [1 ]
Matsumoto, Yosuke [1 ]
Horiike, Shigeo [1 ]
Taniwaki, Masafumi [1 ]
机构
[1] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kamigyo Ku, Kyoto 6028566, Japan
关键词
RESISTANCE;
D O I
10.1007/s00277-014-2214-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:687 / 689
页数:3
相关论文
共 50 条
  • [41] Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
    Philippe Moreau
    Ievgenii I. Karamanesht
    Natalia Domnikova
    Maryna Y. Kyselyova
    Kateryna V. Vilchevska
    Vadim A. Doronin
    Alexander Schmidt
    Cyrille Hulin
    Xavier Leleu
    Dixie-Lee Esseltine
    Karthik Venkatakrishnan
    Donna Skee
    Huaibao Feng
    Suzette Girgis
    Andrew Cakana
    Helgi van de Velde
    William Deraedt
    Thierry Facon
    Clinical Pharmacokinetics, 2012, 51 : 823 - 829
  • [42] Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma
    Moreau, Philippe
    Karamanesht, Ievgenii I.
    Domnikova, Natalia
    Kyselyova, Maryna Y.
    Vilchevska, Kateryna V.
    Doronin, Vadim A.
    Schmidt, Alexander
    Hulin, Cyrille
    Leleu, Xavier
    Esseltine, Dixie-Lee
    Venkatakrishnan, Karthik
    Skee, Donna
    Feng, Huaibao
    Girgis, Suzette
    Cakana, Andrew
    van de Velde, Helgi
    Deraedt, William
    Facon, Thierry
    CLINICAL PHARMACOKINETICS, 2012, 51 (12) : 823 - 829
  • [43] Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group
    Minarik, Jiri
    Pavlicek, Petr
    Pour, Ludek
    Pika, Tomas
    Maisnar, Vladimir
    Spicka, Ivan
    Jarkovsky, Jiri
    Krejci, Marta
    Bacovsky, Jaroslav
    Radocha, Jakub
    Straub, Jan
    Kessler, Petr
    Wrobel, Marek
    Walterova, Lenka
    Sykora, Michal
    Obernauerova, Jarmila
    Gregora, Evzen
    Adamova, Dagmar
    Gumulec, Jaromir
    Adam, Zdenek
    Scudla, Vlastimil
    Hajek, Roman
    BLOOD, 2014, 124 (21)
  • [44] Bortezomib is effective therapy for relapsed multiple myeloma.
    Singhal, S
    Tariman, J
    Smith, K
    Riley, MB
    Mistina, J
    Mehta, J
    BLOOD, 2003, 102 (11) : 390B - 391B
  • [45] BORTEZOMIB IN COMBINATION WITH CYTOTOXIC AGENT THERAPY FOR MULTIPLE MYELOMA
    Takamatsu, Y.
    Sunami, K.
    Miyamoto, T.
    Hata, H.
    Muta, T.
    Tsukada, J.
    Uozumi, K.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [46] Calcium silicate/bortezomib combinatory therapy for multiple myeloma
    Cao, Liqin
    Gu, Huiyao
    Zhang, Zhaowenbing
    Zhang, Enfan
    Chang, Jiang
    Cai, Zhen
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (09) : 1929 - 1939
  • [47] BLOOD DISTRIBUTION OF SUBCUTANEOUS BORTEZOMIB AND ITS KINETICS IN MULTIPLE MYELOMA PATIENTS
    Osawa, Takashi
    Naito, Takafumi
    Mino, Yasuaki
    Kawakami, Junichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S89 - S89
  • [48] Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma
    Hirokazu Miki
    Shuji Ozaki
    Osamu Tanaka
    Etsuko Lee
    Tomomi Takimoto
    Hirofumi Watanabe
    Shiro Fujii
    Shingen Nakamura
    Kumiko Kagawa
    Kyoko Takeuchi
    Ken-ichiro Yata
    Masahiro Abe
    Shoji Kagami
    Toshio Matsumoto
    International Journal of Hematology, 2009, 89 : 223 - 226
  • [49] Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma
    Miki, Hirokazu
    Ozaki, Shuji
    Tanaka, Osamu
    Lee, Etsuko
    Takimoto, Tomomi
    Watanabe, Hirofumi
    Fujii, Shiro
    Nakamura, Shingen
    Kagawa, Kumiko
    Takeuchi, Kyoko
    Yata, Ken-ichiro
    Abe, Masahiro
    Kagami, Shoji
    Matsumoto, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (02) : 223 - 226
  • [50] TREATMENT OF MULTIPLE MYELOMA WITH BORTEZOMIB
    Kodre, Veronika
    Cernelc, Peter
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I87 - I92